Zobrazeno 1 - 10
of 41
pro vyhledávání: '"M P, Link"'
Publikováno v:
European Psychiatry, Vol 64, Pp S463-S464 (2021)
Introduction Positive psychiatry is the science and practice of psychiatry seeking to promote overall well-being and understand the “positive” aspects of the patient’s life, such as resilience, social connections, and meaning and values in life
Externí odkaz:
https://doaj.org/article/46b89885121045c9b9aa468bc4d2870d
Autor:
S. H. Jathar, C. Heppding, M. F. Link, D. K. Farmer, A. Akherati, M. J. Kleeman, J. A. de Gouw, P. R. Veres, J. M. Roberts
Publikováno v:
Atmospheric Chemistry and Physics, Vol 17, Pp 8959-8970 (2017)
Isocyanic acid (HNCO), an acidic gas found in tobacco smoke, urban environments, and biomass-burning-affected regions, has been linked to adverse health outcomes. Gasoline- and diesel-powered engines and biomass burning are known to emit HNCO and
Externí odkaz:
https://doaj.org/article/116f9d300cfe4e798d94e0cf681bce05
Autor:
R O, Bash, W M, Crist, J J, Shuster, M P, Link, M, Amylon, J, Pullen, A J, Carroll, G R, Buchanan, R G, Smith, R, Baer
Publikováno v:
Blood. 81:2110-2117
Alteration of the TAL1 locus is the most common nonrandom genetic defect in childhood T-cell acute lymphoblastic leukemia (T-ALL). To determine if rearrangements of the TAL1 proto-oncogene confer a distinct leukemic phenotype, we studied leukemic per
Autor:
C H, Pui, A J, Carroll, S C, Raimondi, M J, Schell, D R, Head, J J, Shuster, W M, Crist, M J, Borowitz, M P, Link, F G, Behm
Publikováno v:
Blood. 79:2384-2391
Cytogenetic analysis of leukemic cells from 2,805 children with newly diagnosed acute lymphoblastic leukemia (ALL) identified 83 cases (3%) that had a stemline with at least one isochromosome. The i(9q) was present in 28 (1%), the i(17q) in 23 (0.8%)
Publikováno v:
Blood. 77:687-693
The t(1;19)(q23;p13) chromosomal translocation is observed cytogenetically in 25% of children with pre-B-cell acute lymphoblastic leukemia (ALL) and is associated with an adverse treatment outcome. The t(1;19) juxtaposes the E2A gene from chromosome
Autor:
C H, Pui, A J, Carroll, D, Head, S C, Raimondi, J J, Shuster, W M, Crist, M P, Link, M J, Borowitz, F G, Behm, V J, Land
Publikováno v:
Blood. 76:590-596
Cytogenetic and DNA flow cytometric analyses of leukemic cells from 1,971 children with newly diagnosed acute lymphoblastic leukemia (ALL) identified stem lines with modal chromosome numbers greater than 65 in 26 patients (1.3%). Near-triploidy (66 t
Autor:
C A, Arndt, S S, Donaldson, J R, Anderson, R J, Andrassy, F, Laurie, M P, Link, R B, Raney, H M, Maurer, W M, Crist
Publikováno v:
Cancer. 91(12)
Factors affecting outcome for rhabdomyosarcoma (RMS) of the female genital tract in patients treated on Intergroup Rhabdomyosarcoma Study Group (IRSG) protocols I-IV were evaluated to define optimal therapy.Records of 151 patients with tumors of the
Autor:
N R, Schneider, A J, Carroll, J J, Shuster, D J, Pullen, M P, Link, M J, Borowitz, B M, Camitta, J A, Katz, M D, Amylon
Publikováno v:
Blood. 96(7)
To further define the cytogenetic differences between B-cell lineage (B-lineage) acute lymphoblastic leukemia (ALL) and T-cell lineage ALL (T-ALL) and to determine the prognostic value of cytogenetics in childhood T-ALL, the blast cell karyotypes of
Autor:
S S, Donaldson, M, Torrey, M P, Link, A, Glicksman, L, Gilula, F, Laurie, J, Manning, J, Neff, W, Reinus, E, Thompson, J J, Shuster
Publikováno v:
International journal of radiation oncology, biology, physics. 42(1)
To determine if involved field radiation (IF) is equivalent to standard whole bone radiation (SF) in local tumor control; to establish patterns of failure following treatment; and to determine response, event-free survival (EFS), and overall survival
Autor:
S P, Hunger, M Z, Fall, B M, Camitta, A J, Carroll, M P, Link, S J, Lauer, D H, Mahoney, D J, Pullen, J J, Shuster, C P, Steuber, M L, Cleary
Publikováno v:
Blood. 91(3)
A t(1;19)(q23;p13) is detected cytogenetically in approximately 5% of childhood acute lymphoblastic leukemias (ALLs) and its presence has been associated with an increased risk of relapse in several previously-completed Pediatric Oncology Group (POG)